E*TRADE from Morgan Stanley today announced multiple top honors from the StockBrokers.com 2025 Annual Awards. E*TRADE earned 5 out of 5 stars overall and was ranked the #1 Web Trading Platform for the ...

TD Cowen analyst Lance Vitanza maintained a Buy rating on DraftKings (DKNG – Research Report) today and set a price target of $51.00. The ...

In a report released today, Bill Kerr from TD Cowen maintained a Buy rating on Chewy (CHWY – Research Report), with a price target of $45.00.

TD Cowen had upgraded Merck in early 2024 based on confidence in Keytruda and Gardasil’s performance, a lack of binary risks, and an attractive valuation. However, setbacks in Gardasil’s China ...

On Wednesday, TD Securities shifted its stance on ERO Copper Corp (ERO:CN) (OTC: ERRPF), raising the stock rating from Hold to Buy, while adjusting the price target to Cdn$23.00, down from the ...

The TRADE sits down with TD Securities’ Carl Hayes, head of European cash equities, and James Baugh, managing director and head of European market structure, to discuss the integration of TD Execution ...

TransAlta (TSE:TA – Free Report) (NYSE:TAC) had its price objective boosted by TD Securities from C$18.00 to C$19.00 in a research report report published on Tuesday,BayStreet.CA reports.

Investing.com -- TD Cowen downgraded Merck & Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of ...

TD Securities’ purchase of Cowen brought together balance sheet strength with the high-touch investment banking needed to service client growth. For building a combined platform that is greater than ...

A preliminary prospectus supplement relating to the secondary offering of Schwab shares held by TD will be filed by Schwab with the U.S. Securities and Exchange Commission (the "SEC"). TD ...

TD Cowen has upgraded CRISPR Therapeutics (NASDAQ:CRSP) to hold from sell, stating it now sees less downside to the stock. "We believe Casgevy expectations have bottomed out in the near term and ...

Investing.com -- TD Cowen downgraded Merck &Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of ...